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fluorescence microscopy of a viral infection
Cândida F Pereira2,3,4†, Jérémie Rossy1†, Dylan M Owen1, Johnson Mak2,5,6* and Katharina Gaus1*Abstract
Background: The visualization of viral proteins has been hindered by the resolution limit of conventional
fluorescent microscopes, as the dimension of any single fluorescent signal is often greater than most virion particles.
Super-resolution microscopy has the potential to unveil the distribution of proteins at the resolution approaching
electron microscopy without relying on morphological features of existing characteristics of the biological specimen
that are needed in EM.
Results: Using direct stochastic optical reconstruction microscopy (dSTORM) to achieve a lateral resolution of 15–
20 nm, we quantified the 2-D molecular distribution of the major structural proteins of the infectious human
immunodeficiency virus type 1 (HIV-1) before and after infection of lymphoid cells. We determined that the HIV-1
matrix and capsid proteins undergo restructuring soon after HIV-1 infection.
Conclusions: This study provides the proof-of-concept for the use of dSTORM to visualize the changes in the
molecular distribution of viral proteins during an infection.
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rearrangementBackground
The human immunodeficiency virus type 1 (HIV-1) is ap-
proximately spherical with a mean diameter of 125±14 nm
[1-3]. Its main structural components are a lipid bilayer
containing envelope glycoproteins, a matrix shell located
beneath the viral lipid membrane and a capsid core with a
cone shaped geometry [1-3]. After fusion of HIV-1 with the
target cell, it is postulated that the matrix shell is retained at
the plasma membrane while the capsid core undergoes a
dramatic disassembly process that facilitates the reverse
transcription of the viral genome [3-5]. Fluorescent labeling
of HIV-1 proteins has provided valuable insights into their
sub-cellular localization in infected cells [6,7]. However, the
molecular mechanisms of cell entry and replication are diffi-
cult to detect since the viral particle is smaller than the
resolution limit of conventional fluorescent microscopes.
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reproduction in any medium, provided the orinsights of HIV-1 [1,2,7] but remain technically demanding
and are prone to introduce artifacts.
The development of far-field super-resolution light mi-
croscopy methods such as stochastic optical reconstruc-
tion microscopy (STORM) [8] and photoactivatable
localization microscopy (PALM) [9] enable the localization
of individual photoswitchable protein-labeled molecules
with a spatial resolution of tens of nanometers. The more
recently developed direct STORM (dSTORM) combines
standard immunocytochemistry, total internal reflection
fluorescence (TIRF) microscopy and reversible photo-
switching of conventional organic fluorochromes such as
Cy5 and Alexa 647 to further improve the quality of sig-
nals [10]. This technique has a tremendous potential for
the visualization of the molecular organization of viral
proteins during an infection, particularly if tagging with
fluorescent proteins compromises virus infectivity. Previ-
ously studies have used super-resolution techniques to
visualize clusters of viral proteins artificially transfected
into cell lines [11-13]. In this study we have used
dSTORM to provide one of the first the molecular distri-
bution of matrix and capsid proteins in infectious HIV-1
particles before and after a real infection of lymphoid cells.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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We used dSTORM to visualize matrix and capsid pro-
teins in cell-free HIV-1 virions and in infected lymphoid
cells. Similar to previously describe [7,14], we first gener-
ated HIV-1 particles that contained the green fluorescent
protein-viral protein R fusion protein (HIVGFP-Vpr),
which allows us to visualize particles with conventional
fluorescence microscopy. The same virion preparation
was then either evenly spread onto glass coverslips or
used to infect lymphocytes. Importantly, non-interna-
lized viral particles were removed from the surface of the
target cells by pronase treatment twenty minutes after
the virus was allowed to enter the target cells. This was
confirmed by incubation of the target cells with an enve-
lope-deficient HIV-1, which was unable to enter the tar-
get cells and therefore was cleaved by the pronase and
consequently no viral protein could be detected in these
samples (Figure 1). Therefore, all matrix and capsid pro-
tein clusters associated with the lymphocytes were inter-
nalized. Infected cells were fixed and plated onto glass
coverslips by cytospin centrifugation. Both samples were(a)
(c)
Figure 1 Pronase treatment removes non-internalized virus particles
(b, d) HIVΔenvGFP-Vpr for 2 h at 17°C to allow binding of the virions to the ce
particles and incubated for 20 min at 37°C to allow virus entry into the cell
with PBS (a-b) while the other half was treated with pronase (c-d) to remo
counterstained, mounted and visualized by widefield microscopy followed
provided images were derived from a volume compression of a z stack of
representative of 3 independent experiments.immuno-stained with antibodies recognizing either the
matrix or caspid protein.
We first compared conventional to super-resolution
images. In TIRF images, HIV-1 proteins in infected T-
lymphocytes appeared as bright punctuate structures
(Figure 2a). In dSTORM, the stochastic activation of
fluorophores allows the analysis of the point-spread
function (PSF) of individual proteins. In addition to the
x-y localization, the fitting algorithms also return the
localization precision, number of photons emitted per
molecules, and background values associated with each
molecule. These characteristics allow us to apply strin-
gent conditions for single molecule detection [15] and
standardize the image quality across the experimental
conditions. When the molecular coordinates of the indi-
vidual matrix proteins are plotted in an image, it
becomes apparent that dSTORM revealed a greater het-
erogeneity in distribution of the same protein than in
TIRF images (Figure 2b). The increase in resolution
achieved with dSTORM is illustrated by the overlay of
the two images with protein clusters in dSTORM(b)
(d)
from the cell surface. MT-2 cells were infected with (a, c) HIVGFP-Vpror
lls. Afterwards the cells were washed to remove unbound virus
s. The samples were then split and half of the cells were incubated
ve non-internalized virus particles. Subsequently, all samples were fixed,
by deconvolution. GFP is shown in green and nuclei in blue. The
28 images taken at a 0.3-μm step size. Scale bar, 5 μm. Images are
Figure 2 Super-resolution imaging of individual molecules of infectious HIV-1 before and after entry into lymphocytes. (a-c)
Conventional total internal reflection fluorescence (TIRF) image (a), corresponding dSTORM image (b) and overlay of the TIRF (white) and dSTORM
(red) images (c) of the HIV-1 matrix protein 20 minutes after synchronized entry into the lymphoid cell line MT-2. (d) Histogram of the localization
precision values of molecular coordinates localized by dSTORM corresponding to the data set shown in a-c. Localization precision corresponds to
one sigma of the Gaussian distribution of the point spread function that is fitted to individual molecules and is also affected by photons and
noise level. Dashed line indicates mean. (e-h) Cluster analysis of the matrix protein in cell-free virions based on Ripley’s K-function converts the
point distribution of molecular coordinates (e) into a cluster map with highly to less clustered regions colored red to blue (f). Cluster statistics
such as number, size and associated molecules were extracted from thresholded images (g). By overlaying the TIRF image of GFP-Vpr (green) with
the binary cluster map, the association of viral proteins with the reverse transcription complex after cell entry was quantified (h). Scale bars, 5 μm
in panels in a-b; 1 μm in panel c and 2 μm in panels e-h. (i) Quantitative analysis of the diameter of the molecular clusters of capsid proteins in
cell-free virions and 20 min post infection into MT-2 cells. Error bars represent the standard deviation of the mean from 26–173 clusters per
sample from a representative from two experiments. *** = p< 0.001; ns = non-significant.
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image (Figure 2c). The molecular localization precision
of the dSTORM approach was 15–20 nm (Figure 2d).
To quantify the distribution and heterogeneity of viral
proteins, we used a variation on Ripley’s K- function ana-
lysis [16]. As shown for the matrix protein in cell-free
HIV-1 (Figure 2e-h), the single molecule dSTORM
image was converted into a pseudo-colored cluster map
that is based on the number of other molecules within a
50 nm radius, normalized to the overall particle density
(Figure 2f). The contours describing each cluster were
extracted and the number of clusters and cluster sizes
determined (Figure 2g). To identify the replicating
viruses that are travelling to the nucleus we used the
GFP-Vpr fusion protein, which is incorporated into thevirus particles and remains associated with the replicat-
ing viruses during intracellular trafficking [7]. GFP-Vpr
was therefore used to identify ‘double positive’ viral pro-
tein clusters that were associated with the viral replica-
tion machinery and contained the matrix or capsid
protein (Figure 2h).
This analysis allowed us to accurately measure the
sizes of matrix and capsid protein clusters co-localized
with GFP-Vpr in cell-free virons and in infected cells
(Figure 2i). In cell-free virions, the size of the matrix pro-
tein clusters are within the expected range of 106–
183 nm [1] and, as expected, the size of the capsid pro-
tein clusters are significantly smaller than the matrix
protein clusters (p< 0.0001, Figure 2i). Twenty minutes
post infection of T lymphocytes, the matrix protein
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size (Figure 2i), which indicates that upon infection the
capsid protein clusters showed a significantly large frac-
tional increase in size (236%) when compared with the
matrix protein clusters. This single molecule imaging ap-
proach hence allowed us to follow the restructuring of
the matrix shell and capsid core during infection, which
may reflect the structural rearrangements that facilitate
the HIV-1 reverse transcription process, such as virion
uncoating.
Conclusion
We were able to quantify the size of the HIV-1 matrix
shell and capsid core by dSTORM and these results were
in agreement with the known HIV organization seen by
EM [1,2,17]. Furthermore, this approach provided new
information showing that upon cell entry, the size of the
virion matrix shell and capsid core increased significantly
when compared to cell-free HIV-1 virions, which indi-
cates that the HIV particles underwent a dramatic re-
arrangement immediately after entry into the target cell.
In summary, this study validates the use of dSTORM to
assess the molecular distribution of viral proteins during
the life-cycle of an infectious virus, and it opens up new
possibilities to study the distribution and re-distribution
of viral proteins at the early phase of viral infection.
Methods
Cells and virus
MT-2 cells (obtained through the AIDS Research and
Reference Reagent Program, Division of AIDS, NIAID,
NIH from D. Richman) [18,19] were cultured in Rosewell
Park Memorial Institute (RPMI) 1640 medium (Invitro-
gen) supplemented with 10% vol/vol heat-inactivated
fetal calf serum (FCS; Invitrogen, Mount Waverley, Vic-
toria, Australia) and penicillin/streptomycin. 293 T cells
were maintained in Dulbecco’s modified Eagle medium/
high modified (with 4500 mg/l dextrose and 4 mM L-
glutamine) medium (DMEM; Invitrogen), supplemented
with 10% (vol/vol) heat-inactivated cosmic calf serum
(CCS; Hyclone, Tauranga, New Zealand), 100 U/ml of
penicillin and 100 mg/ml of streptomycin (Invitrogen).
The pNL4-3 proviral DNA (obtained through the
AIDS Research and Reference Reagent Program, Division
of AIDS, NIAID, NIH from M. Martin [20]) contains the
NL4-3 infectious molecular clone of HIV-1. The pNL4-
3Δenv proviral DNA (obtained through the AIDS Re-
search and Reference Reagent Program, Division of
AIDS, NIAID, NIH from N. Landau [21,22]) contains an
envelope defective-pNL4-3 molecular clone of HIV-1.
HIV-1 particles were produced by poly(ethylenimine)
(PEI; Polysciences Inc., Warrington, PA, USA) transfec-
tion of 293 T cells with pNL4-3 or pNL4-3Δenv proviral
DNA and GFP-Vpr plasmid (kindly provided by T. Hope,Northwestern University) to generate GFP-Vpr-labeled
HIV-1 (HIVGFP-Vpror HIVΔenvGFP-Vpr). Forty hours post-
transfection viral particles were purified, concentrated
and quantified as previously described [14]. Briefly,
supernatant from 293 T cells was filtered and viral parti-
cles were concentrated by ultracentrifugation through a
20% sucrose cushion at 100,000 x g for 1 h at 4°C using
an L-90 ultracentrifuge (SW 41 rotor; Beckman, Fuller-
ton, CA, USA) and virus pellets were resuspended in 1x
phosphate buffered saline (PBS; Invitrogen) and quanti-
fied using a HIV-1 antigen (p24 CA) micro enzyme-
linked immunosorbent assay (ELISA) (Vironostika: Bio-
merieux, Boxtel, The Netherlands).Infection of lymphoid cells
Synchronized infections were performed as described
previously [23]. Briefly, MT-2 cells were infected with
HIVGFP-Vpr (normalized to 1000 ng of p24 per million
cells) by spinoculation at 17°C for 2 h at 1,200 x g. After-
wards, the cells were washed twice with PBS to remove
unbound virus and incubated with warm media at 37°C,
5% CO2 for 20 min to initiate infection. Afterwards, the
cells were washed, treated with 2 mg/ml of protease
from Streptomyces griseus (pronase E; Sigma-Aldrich,
Castle Hill, NSW, Australia) for 10 min on ice and
washed extensively with PBS containing 20% FCS. The
cells were then fixed with 4% formaldehyde (Poly-
sciences) in 0.1 M pipes buffer, pH 6.8, washed with PBS
and cytospined onto glass coverslips. Cell-free viruses
(same batch as used for the infection of lymphoid cells)
were also fixed with formaldehyde in pipes buffer, evenly
spread on glass slides to achieve optimal sample thick-
ness, incubated at 4°C for 16 h and washed twice with
PBS.Immunofluorescence staining
Cells and virus were permeabilized and stained with
mouse anti-matrix (SVM-33) antibody (MH-SVM33C9,
ATCC, Manassas, VA (Akzo Nobel N.V.) or mouse anti-
capsid (AG3.0) antibody (obtained through the AIDS Re-
search and Reference Reagent Program, Division of
AIDS, NIAID, NIH from J. Allan) [24] and goat Cy5-
conjugated anti-mouse secondary antibody (Jackson
ImmunoResearch, USA).Image acquisition and analysis
Antibody stained cells were imaged in an oxygen scaven-
ging buffer (50 μ g/ml glucose oxidase, 25 μ g/ml horse-
radish peroxidase, 75 mM β-mercaptoethylamine,
25 mM Hepes, 25 mM glucose, 5% glycerol in PBS, pH
8) in an open Chamlide™ chamber (Live Cell Instrument,
Seoul, Korea). Cells were imaged with surface-immobi-
lized 100 nm colloidal gold beads (BBInternational,
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the acquisition.
dSTORM images were acquired on a prototype PALM
microscope (Carl Zeiss GmbH, Jena, Germany) with
TIRF illumination. In dSTORM, the carbocyanine dye
Cy5 is stochastically converted to a long-lived dark state
(‘off ’) when excited using 633 nm (15 mW) laser radi-
ation and switched back ‘on’ by exposure to low inten-
sities of 488 nm (0.1–1 mW) laser light when the sample
is immersed in a oxygen depleted buffer containing a re-
ducing agent [10]. By adjusting the intensity of the
488 nm laser, the density of fluoroescent molecules was
approximately kept constant during acquisition and
across samples. Images of 5–6 cells per sample from two
different experiments were captured using an Andor
iXon DU-897D EMCCD camera (Andor Technology Plc,
Belfast, UK), giving a pixel size of 100 nm at the sample
plane.
dSTORM images were reconstructed from a series of
20,000 TIRF images using Zeiss Zen software. Molecular
clustering was analyzed using Getis and Franklins 2nd
order analysis as previously described [25]. Localization
precision corresponds to one sigma of the Gaussian dis-
tribution of the point spread function that is fitted to in-
dividual molecules and is also affected by photons and
noise level [16]. Data was cropped so as to exclude
points with localization precision worse than 50 nm. A
10 × 10 μm region is then selected for analysis and ren-
dered into cluster maps with 7 nm/pixel resolution.
Cluster maps were threshold to create a binary map from
which only clusters that significantly overlapped with a
TIRF image of GFP-Vpr were selected and analyzed
using ImageJ [26].Pronase treatment efficiency
MT-2 cells were infected with HIVGFP-Vpr or HIVΔenvGFP-
Vpr as described above and afterwards the samples were
split. Half of the cells were treated with pronase to re-
move non-internalized virus as described above and half
of the cells were incubated with PBS. The cells were then
cytospined onto glass slides, counterstained with
Hoechst 33258 (Invitrogen), mounted in Fluoromount-G
(Electron Microscopy Sciences, Hatfield, PA) and images
were captured in a z series on a charge-coupled device
(CCD) camera (CoolSnap HQ; Photometrics, Tucson,
AZ) through a 100 × 1.4 numerical aperture (NA) oil
immersion lens on a DeltaVision microscope (Applied
Precision, Issaquah, WA) and deconvolved using soft-
WoRx deconvolution software (Applied Precision).Statistical analysis
Data derived from the diameter of 26–173 molecular
clusters per sample was analyzed by paired two-tailedStudent’s t test. A p value< 0.001 was considered highly
statistically significant for all tests.
Competing interests
The authors declare that they have no competing interests.
Acknowledgments
We acknowledge the financial support from the National Health and Medical
Research Council of Australia (C.F.P., J.M., K.G.), the Australian Research
Council (K.G., D.O., J.M.), Human Frontier Science Pro- gram (K.G.), the
European Social Fund of the European Commission (C.F.P.) and the
Portuguese Foundation for Science and Technology (C.F.P.). J.M. is a recipient
of the Pfizer Foundation Fellowship and ARC Future Fellowship. We thank T.
Hope for the GFP-Vpr plasmid and S. Turville for the MH-SVM33C9 purified
hybridoma supernatant.
Author details
1Centre for Vascular Research, University of New South Wales, Sydney,
Australia. 2Centre for Virology, Burnet Institute, Melbourne, Australia. 3Monash
Micro Imaging, Clayton, Australia. 4Department of Medicine, Monash
University, Clayton, Australia. 5School of Medicine, Deakin University, Geelong,
Australia. 6Commonwealth Scientific and Industrial Research Organization,
Australian Animal Health Laboratory, Geelong, Australia.
Author’s contributions
CFP carried out the virus components of this study in the Mak lab (JM) at
Burnet Institute; JR and DMO conducted the dSTORM imaging and analyses
in the Gaus lab (KG) at UNSW. All authors contributed to the design, data
interpretation and writing of the manuscript. All authors read and approved
the final manuscript.
Received: 9 November 2011 Accepted: 2 May 2012
Published: 2 May 2012
References
1. Briggs JA, Grunewald K, Glass B, Forster F, Krausslich HG, Fuller SD: The
mechanism of HIV-1 core assembly: insights from three-dimensional
reconstructions of authentic virions. Structure 2006, 14:15–20.
2. Goto T, Nakai M, Ikuta K: The life-cycle of human immunodeficiency virus
type 1. Micron 1998, 29:123–138.
3. Miller MD, Farnet CM, Bushman FD: Human immunodeficiency virus type
1 preintegration complexes: studies of organization and composition. J
Virol 1997, 71:5382–5390.
4. Karageorgos L, Li P, Burrell C: Characterization of HIV replication
complexes early after cell-to-cell infection. AIDS Res Hum Retroviruses 1993,
9:817–823.
5. Yamashita M, Perez O, Hope TJ, Emerman M: Evidence for direct
involvement of the capsid protein in HIV infection of nondividing cells.
PLoS Pathog 2007, 3:1502–1510.
6. Arhel N, Genovesio A, Kim KA, Miko S, Perret E, Olivo-Marin JC, Shorte S,
Charneau P: Quantitative four-dimensional tracking of cytoplasmic and
nuclear HIV-1 complexes. Nat Methods 2006, 3:817–824.
7. McDonald D, Vodicka MA, Lucero G, Svitkina TM, Borisy GG, Emerman M,
Hope TJ: Visualization of the intracellular behavior of HIV in living cells. J
Cell Biol 2002, 159:441–452.
8. Rust MJ, Bates M, Zhuang X: Sub-diffraction-limit imaging by stochastic
optical reconstruction microscopy (STORM). Nat Methods 2006, 3:793–795.
9. Betzig E, Patterson GH, Sougrat R, Lindwasser OW, Olenych S, Bonifacino JS,
Davidson MW, Lippincott-Schwartz J, Hess HF: Imaging intracellular
fluorescent proteins at nanometer resolution. Science 2006, 313:1642–
1645.
10. Heilemann M, van de Linde S, Schuttpelz M, Kasper R, Seefeldt B, Mukherjee
A, Tinnefeld P, Sauer M: Subdiffraction-resolution fluorescence imaging
with conventional fluorescent probes. Angew Chem Int Ed Engl 2008,
47:6172–6176.
11. Hess ST, Gould TJ, Gudheti MV, Maas SA, Mills KD, Zimmerberg J: Dynamic
clustered distribution of hemagglutinin resolved at 40 nm in living cell
membranes discriminates between raft theories. Proc Natl Acad Sci U S A
2007, 104:17370–17375.
Pereira et al. Virology Journal 2012, 9:84 Page 6 of 6
http://www.virologyj.com/content/9/1/8412. Eckhardt M, Anders M, Muranyi W, Heilemann M, Krijnse-Locker J, Muller B:
A SNAP-tagged derivative of HIV-1–a versatile tool to study virus-cell
interactions. PLoS One 2011, 6:e22007.
13. Lehmann M, Rocha S, Mangeat B, Blanchet F, Uji IH, Hofkens J, Piguet V:
Quantitative multicolor super-resolution microscopy reveals tetherin HIV-
1 interaction. PLoS Pathog 2011, 7:e1002456.
14. Pereira CF, Ellenberg PC, Jones KL, Fernandez TL, Smyth RP, Hawkes DJ,
Hijnen M, Vivet-Boudou V, Marquet R, Johnson I, Mak J: Labeling of
multiple HIV-1 proteins with the biarsenical-tetracysteine system. PLoS
One 2011, 6:e17016.
15. Williamson DJ, Owen DM, Rossy J, Magenau A, Wehrmann M, Gooding JJ,
Gaus K: Pre-existing clusters of the adaptor Lat do not participate in early
T cell signaling events. Nat Immunol 2011, 12:655–662.
16. Owen DM, Rentero C, Rossy J, Magenau A, Williamson D, Rodriguez M, Gaus
K: PALM imaging and cluster analysis of protein heterogeneity at the cell
surface. J Biophotonics 2010, 3:446–454.
17. Welker R, Hohenberg H, Tessmer U, Huckhagel C, Krausslich HG:
Biochemical and structural analysis of isolated mature cores of human
immunodeficiency virus type 1. J Virol 2000, 74:1168–1177.
18. Harada S, Koyanagi Y, Yamamoto N: Infection of HTLV-III/LAV in HTLV-I-
carrying cells MT-2 and MT-4 and application in a plaque assay. Science
1985, 229:563–566.
19. Haertle T, Carrera CJ, Wasson DB, Sowers LC, Richman DD, Carson DA:
Metabolism and anti-human immunodeficiency virus-1 activity of 2-halo-
2′,3′-dideoxyadenosine derivatives. J Biol Chem 1988, 263:5870–5875.
20. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA:
Production of acquired immunodeficiency syndrome-associated
retrovirus in human and nonhuman cells transfected with an infectious
molecular clone. J Virol 1986, 59:284–291.
21. He J, Choe S, Walker R, Di Marzio P, Morgan DO, Landau NR: Human
immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2
phase of the cell cycle by inhibiting p34cdc2 activity. J Virol 1995,
69:6705–6711.
22. Connor RI, Chen BK, Choe S, Landau NR: Vpr is required for efficient
replication of human immunodeficiency virus type-1 in mononuclear
phagocytes. Virology 1995, 206:935–944.
23. O’Doherty U, Swiggard WJ, Malim MH: Human immunodeficiency virus
type 1 spinoculation enhances infection through virus binding. J Virol
2000, 74:10074–10080.
24. Simm M, Shahabuddin M, Chao W, Allan JS, Volsky DJ: Aberrant Gag
protein composition of a human immunodeficiency virus type 1 vif
mutant produced in primary lymphocytes. J Virol 1995, 69:4582–4586.
25. Perry GLW: SpPack:spatial point pattern analysis in Excel using Visual
Basic for Applications (VBA). Environ Model Softw 2004, 19:559–569.
26. Abramoff MD, Magelhaes PJ, Ram SJ: Image Processing with ImageJ.
Biophotonics Int 2004, 11:36–42.
doi:10.1186/1743-422X-9-84
Cite this article as: Pereira et al.: HIV taken by STORM: Super-resolution
fluorescence microscopy of a viral infection. Virology Journal 2012 9:84.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
